Comparing quality of life in women with vulvovaginal lichen planus treated with topical and systemic treatments using the vulvar quality of life index

• Published in: Australasian journal of dermatology Vol. 64; no. 2; pp. e125 - e134
• Main Authors: Kherlopian, Ashod, Fischer, Gayle
• Format: Journal Article
• Language: English
• Published: Australia Wiley Subscription Services, Inc 01.05.2023
• Subjects: Activities of Daily Living; Adult; Cohort analysis; Cohort Studies; Corticosteroids; Electronic medical records; Female; genital; Humans; Immunosuppression; Immunosuppressive Agents; Lichen planus; Lichen Planus - diagnosis; Lichen Planus - drug therapy; Monoclonal antibodies; mucosal lichen planus; Patients; Quality of Life; Remission; Retrospective Studies; Statistical analysis; tildrakizumab; Vulvar Diseases - diagnosis; Vulvar Diseases - drug therapy; tildrakizumab; genital; lichen planus; mucosal lichen planus

Background/Objectives For patients with vulvovaginal lichen planus (VLP), there exists limited data on the comparison between patient quality of life treated with topical and/or systemic treatments. We characterised the treatment outcomes of VLP using the vulvar quality of life index (VQLI) comparin...